Eli Lilly is the clear leader in the burgeoning weight loss market. Its lineup and pipeline put it well ahead of even its ...

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them ...

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...

People covered by Obamacare and Medicaid may see health care costs rise, but for people on Medicare, Biden-era negotiated ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. Trading was extremely light ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management ...

The era of "oral obesity drugs" has officially begun as Danish pharmaceutical company Novo Nordisk’s obesity treatment received U.S. Food and Drug Administration (FDA) approval in pill form. This is ...

NEW YORK -- Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The S&P 500 ...

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...